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ABSTRACT
The nervous system displays a daunting cellular diversity. Neuronal
subtypes differ from each other in several aspects, including
their neurotransmitter expression and axon projection. These
aspects can converge, but can also diverge, such that neurons
expressing the same neurotransmitter may project axons to different
targets. It is not well understood how regulatory programs converge/
diverge to associate/dissociate different cell fate features. Studies
of the Drosophila Tv1 neurons have identified a regulatory
cascade, ladybird early→collier→apterous/eyes absent→dimmed,
that specifies Tv1 neurotransmitter expression. Here, we conduct
genetic and transcriptome analysis to address how other aspects of
Tv1 cell fate are governed. We find that an initiator terminal selector
gene triggers a feedforward loop that branches into different
subroutines, each of which establishes different features of this one
unique neuronal cell fate.
KEY WORDS: Cell fate specification, Terminal selector,
Axon pathfinding, Genetic cascades, Feedforward loops
INTRODUCTION
The nervous system contains many different neuronal subtypes and
understanding cell fate specification remains a major challenge.
Mature neurons differ from each other with respect to a number
of different properties, including neurotransmitter identity,
electrophysiological properties and axon/dendrite morphology.
These different properties are not always linked. For example,
neurons producing the same neurotransmitter may project axons to
different targets, and neurons projecting to the same target may
produce different neurotransmitters. In addition, related neurons
may originate from different progenitors and different locations with
the CNS. This begs the question of how the developmental
regulatory machinery can determine which features to combine in
order to establish a particular cell fate. Although a number of studies
have focused on the genetic programs determining one specific
aspect of a neuronal cell fate, few studies have addressed multiple
aspects simultaneously. The exception is studies in C. elegans,
which have involved a comprehensive analysis of the regulatory
programs dictating most, if not all, aspects of terminal neuron cell
fate for several specific neurons (reviewed by Hobert, 2016; Hobert
et al., 2010). This has unravelled several intriguing principles
underlying neuronal subtype specification. However, it remains
unclear how regulatory cascades are integrated to determine all
aspects of neuronal subtype identity in animals with thousands of
neurons and hundreds of cell fates.
The Apterous (Ap) neurons of the Drosophila ventral nerve cord
(VNC) constitute a powerful model for addressing these issues,
because of the availability of selective markers and genetic tools, as
well as the insight available into their specification that stems from
previous extensive work (reviewed by Allan and Thor, 2015).
Ap neurons constitute a small subgroup of interneurons that express
the Apterous (Ap) LIM-homeodomain factor and the Eyes absent
(Eya) transcriptional co-factor and nuclear phosphatase (Fig. 1A)
(Lundgren et al., 1995; Miguel-Aliaga et al., 2004). A subset of Ap
neurons expresses the Nplp1 neuropeptide: the lateral thoracic Tv1
neurons, part of the thoracic Ap cluster of four cells, and the dorsal
medial row of dAp neurons (Fig. 1A,B) (Baumgardt et al., 2007;
Park et al., 2004). In line with the different position of the Tv1 and
dAp neurons, previous studies have revealed that they originate from
two different progenitors (neuroblasts, NBs): NB5-6T and NB4-3,
respectively (Baumgardt et al., 2009; Gabilondo et al., 2016).
In addition to their expression of the same neuropeptide, Tv1 and
dAp neurons also project their axons along a common route,
ipsilaterally and anteriorly along the medial-most Fasciclin II
(FasII)-positive axon bundle (Fig. 1A,B) (Lundgren et al., 1995). In
addition to expressing the Nplp1 neuropeptide, Tv1 and dAp are
similar with respect to their secretory properties. Specifically, their
neuropeptide expression necessitates the co-expression of a number
of genes involved in the processing of neuropeptides, as well as the
establishment of secretory large dense-core vesicles (Allan et al.,
2005; Park et al., 2004, 2008b). These features are collectively
referred to as the regulated secretory pathway (Park and Taghert,
2009). Thus, Tv1 and dAp neurons share three defining features:
their axon pathfinding; the expression of the Nplp1 neuropeptide;
and the expression of the regulated secretory pathway.
A number of studies have addressed the molecular genetic
underpinnings of Tv1 and dAp neuron specification, both with
respect to axonal projection, the expression of the Nplp1
neuropeptide and establishment of the regulated secretory
pathway. These studies have identified two distinct spatio-
temporal combinatorial transcription factor codes, one acting in
NB5-6T and the other in NB4-3, that dictate Tv1 and dAp fate,
respectively (Gabilondo et al., 2016). In NB5-6T, these upstream
cues involve the ladybird early (lbe) gene, which activates the
collier gene (col; kn – Flybase), encoding a COE/EBF transcription
factor (Fig. 1B) (Baumgardt et al., 2009; Gabilondo et al., 2016;
Karlsson et al., 2010). Lbe and Col then trigger a feed-forward loop
(FFL) consisting of Ap, Eya and the Dimmed (Dimm) bHLH
transcription factor, which together activate the Nplp1 gene
(Baumgardt et al., 2007; Stratmann and Thor, 2017). In addition,
Ap and Eya have been found to play crucial roles in Tv1 and dAp
axon pathfinding (Lundgren et al., 1995; Miguel-Aliaga et al.,Received 27 November 2018; Accepted 22 February 2019
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2004), while Dimm appears to be necessary and sufficient for
establishing the regulated secretory pathway (Allan et al., 2005;
Hamanaka et al., 2010; Hewes et al., 2006; Park et al., 2011, 2004,
2014, 2008a,b). These genetic studies have shed light upon the cell
specification of Tv1 and dAp neurons with respect to the
neuropeptide Nplp1 and the regulated secretory pathway.
However, they have not addressed the role of each regulator with
respect to axon pathfinding, or resolved the full gene expression
signature of these neurons regarding regulatory cascades and
effector outputs.
To address these issues, we focus here on the Tv1 neurons, which
are generated by NB5-6T. We find that both col and lbe are crucial
for Tv1 axon pathfinding. In addition, co-misexpression of col/lbe is
sufficient to ectopically re-route other neurons into the Tv1 fascicle.
The strength of this effect prompted us to conduct transcriptome
analysis, attempting to unravel the full Tv1 signature. As
anticipated, this identified ap, eya and dimm as being
transcriptionally upregulated. We also observed transcriptional
upregulation of many genes involved in the regulated secretory
pathway, presumably as an effect of dimm upregulation. In addition
to ap, eya and dimm, we observed altered expression of two
additional transcription factor genes: nerfin-1 and Dbx, as well as
of a number of axon pathfinding genes, including uncoordinated-
104 (unc-104), golden goal (gogo) and futsch. Mutant and
misexpression analysis of the genes identified by transcriptomic
analysis revealed different effects upon Tv1 neuron specification.
In line with genetic analysis (herein and previously conducted),
co-misexpression of ap/eya followed by transcriptome analysis
Fig. 1. Co-misexpression of col and lbe results in ectopic Tv1 cells. (A) Nplp1-CRM-myrRFP (RFP false coloured in green) and FasII expression at stage
AFT reveal the axon projections of the Nplp1-positive neurons. myrRFP and FasII overlap along the medial-most FasII-positive axon bundle (orange arrows).
(B) Cartoon depicting that both the Nplp1-positive dorsal dAp neurons, found along the VNC, and the thoracic Tv1 neurons project their axons along the medial
FasII-positive bundle. (C) Regulatory cascade for Tv1 specification, with lbe, col, ap, eya and dimm acting in a feed-forward loop (FFL) to specify the Tv1 cell identity.
ap and eya have previously been shown to be involved in axon guidance. However, the role of col and lbe in regulating axon projections of the Tv1 neurons,
and any downstream genes involved, was hitherto unknown. (D,E) Embryonic stage AFT VNCs stained for Eya, Dimm and Nplp1 in control and UAS-col,lbe
misexpression, driven byelav-Gal4. col/lbemisexpression (E) results in ectopic Eya, Dimmand Nplp1 expression. (F,G) VNCs of control and elav-Gal4/UAS-col,lbe
misexpression at AFT, stained for FasII, Ap and Nplp1, showing that col/lbe misexpression (G) results in ectopic Ap and Nplp1 expression. Co-misexpression
of col/lbe also results in changes to the FasII-positive axon scaffold, and accumulation of ectopic Nplp1-positive axons along themedial-most FasII-positive bundle.
Genotypes: (A) Nplp1-CRM-myrRFP; (D,F) OregonR; (E,G) elav-Gal4/UAS-col,UAS-lbe.
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revealed a smaller number of genes that were mis-regulated.
Together with previous studies on Tv1 neurons, these findings point
to a branching neuronal cell fate specification model, where the
different regulators play partly overlapping, but also unique roles
with respect to neurotransmitter, axon pathfinding and secretory
properties. Such branching regulatory networks are likely to be
prevalent in more-complex nervous systems.
RESULTS
ladybird early and collier combinatorially govern Tv1 axon
pathfinding and neurotransmitter identity
The activation of the Nplp1 neuropeptide in Tv1 and dAp neurons
is controlled by a shared coherent FFL, consisting of col, ap, eya
and dimm (Baumgardt et al., 2007; Gabilondo et al., 2016).
Tv1 and dAp neurons are generated by two different NBs, NB5-6T
and NB4-3, respectively, and, hence, the FFL is triggered by
two different upstream spatio-temporal combinatorial codes
(Baumgardt et al., 2009; Gabilondo et al., 2016; Karlsson et al.,
2010). In NB5-6T these upstream cues include the homeobox gene
lbe (Fig. 1C).
The Tv1 and dAp neurons both project axons ipsilaterally and
anteriorly, into a common fascicle that overlaps with the medial-
most bundle identified by the axon fascicle marker FasII (Fig. 1A,B)
(Lundgren et al., 1995). ap and eya have both been found to control
proper axon pathfinding of Tv1/dAp neurons (Lundgren et al.,
1995; Miguel-Aliaga et al., 2004), whereas dimm is not involved in
axon pathfinding (Allan et al., 2005). The roles of lbe and col with
respect to axon pathfinding have not been addressed previously. To
unravel the roles of the identified regulators in axon pathfinding, we
focus on the Tv1 neurons.
We have previously found that combinatorial misexpression of
col and lbe was sufficient to trigger widespread specification of
ectopic Tv1 neurons, evident by ectopic Ap, Eya, Dimm and Nplp1
expression (Gabilondo et al., 2016). We repeated this experiment,
using the pan-neural elav-Gal4 driver, and confirmed ectopic
expression of Ap, Eya, Dimm andNplp1 (Fig. 1D,E). As anticipated
from previous studies (Baumgardt et al., 2009, 2007; Gabilondo
et al., 2016; Stratmann et al., 2016), co-misexpression of col and lbe
did not activate expression of the FMRFa neuropeptide, expressed
by the Tv4 and SE2 neurons, but rather downregulated its
expression (Fig. S1A-H). In addition, based upon the Nplp1
expression, ectopic neurons project axons into a common medial
fascicle, similar in location to the normal Tv1/dAp fascicle (Fig.
1D,E). This axon projection effect was also evident when staining
for FasII, revealing axon re-routing into the medial-most FasII-
positive bundle, and a reduction of the number of FasII-positive
bundles (Fig. 1F,G, Fig. S2E-K).
Although both ap and eya are necessary for Nplp1 expression and
proper axon pathfinding of Nplp1-positive neurons, combinatorial
misexpression of ap/eya was not sufficient to trigger ectopic Nplp1
expression (Fig. S2A,B) (Baumgardt et al., 2007). In addition, we
did not observe any apparent changes to the FasII-positive axon
scaffold (Fig. S2C,D). The striking difference in axon pathfinding
effects when comparing col/lbe co-misexpression with ap/eya
co-misexpression indicates that col and lbe have roles in axon
pathfinding independent of their activation of ap and eya.
ladybird early and collier combinatorially re-route axons to
the Tv1 axon fascicle
The disorganized FasII-positive axon scaffold observed in col/lbe
co-misexpression from the pan-neural elav-Gal4 driver raised the
possibility that col/lbe may be chiefly activating Nplp1 in neurons
already projecting in a medial pathway, rather than simultaneously
triggering Nplp1 expression and axon projection changes. To
address this, we misexpressed col/lbe using the more-restricted
wg-Gal4 driver, which expresses in only one of the seven rows of
NBs: row 5 (Chu-LaGraff and Doe, 1993). To reveal axonal
projections, we co-expressed the membrane-targeted UAS-EGFPF
transgene (Allan et al., 2003). In line with previous mapping studies
of NB lineages in the embryonic VNC (Schmid et al., 1999;
Schmidt et al., 1997), in control, neurons generated from row 5 NBs
project axons along several different pathways, including several of
the longitudinal FasII-positive bundles and motor nerves (Fig. 2A,
C). Strikingly, in wg>col,lbe co-misexpressing embryos, we
observed extensive ectopic projections into the medial-most FasII-
positive bundle, as well as an apparent complete loss of motor nerve
projections (Fig. 2B,D, Figs S3A-N, S4A-C). This effect was
evident already at stage (St) 16 but became more pronounced by air-
filled trachea (AFT) stage (Fig. 2A-D, Fig. S3A-N).
To determine the individual effects of col and lbe, we
misexpressed them alone and in combination, and quantified the
extent of axon re-routing by comparing the integrated GFP-intensity
in the medial-most FasII-positive bundle in the region between the
commissures (Fig. S5K). We found that col single misexpression
had a small but significant effect (Fig. S5A,B,E). In contrast, single
lbe misexpression resulted in a significant reduction of axons in the
medial-most FasII-positive bundle (Fig. S5C,E). The reduction of
the medial projection in lbe single misexpression may be due to the
effect of lbe acting without col. Specifically, early-born NB5-6T
neurons, which express lbe and not col (Baumgardt et al., 2009,
2007; Gabilondo et al., 2016), project to the lateral-most FasII-
positive bundle, whereas late-born neurons (Ap neurons), which
express col and lbe, project to the medial-most bundle (Fig. 3A-E).
col/lbe co-misexpression resulted in striking combinatorial effects,
with more than a fourfold increase in GFP signal in the medial-most
FasII-positive bundle, when compared with control (Fig. S5D,E).
In spite of the lack of obvious effects upon the FasII-positive
scaffold in response to ap/eya co-misexpression, when driven from
elav-Gal4, the higher resolution of the wg-Gal4, UAS-EGFPF
driver set-up prompted us to re-address the effects of ap and eya.
Indeed, using this driver-marker combination, we observed weak,
but significant, re-routing to the medial-most FasII-positive bundle
in both ap and eya single misexpression (Fig. S5F-H,J). These
effects were enhanced in the ap/eya co-misexpression embryos
(Fig. S5I,J). However, the ap/eya combinatorial effect was weaker
than that of col/lbe co-misexpression, again supporting the notion
that col and lbe have axon pathfinding roles outside of their
activation of ap and eya.
collier and ladybird early are necessary for Tv1 axon
pathfinding
Next, we addressed the mutant effects of col and lbe upon Ap
neurons and Tv1 axon pathfinding. To achieve this, we could not
use ap, eya, dimm or Nplp1 axonal reporters, because these genes
are all downregulated in col and lbe mutants (Baumgardt et al.,
2007; Gabilondo et al., 2016). Hence, we made use of the lbe(K)-
EGFP transgenic reporter, which labels the entire NB5-6T lineage
(Baumgardt et al., 2009). However, because lbe(K)-GFP labels the
entire lineage, we first needed to map the subset of NB5-6T
projections that correspond to the Ap neurons (including Tv1).
Hence, we combined lbe(K)-GFP with ap-tau-lacZ (Lundgren
et al., 1995), and co-stained for GFP, β-gal and FasII. This analysis
revealed the development of the entire NB5-6T lineage projections,
the Ap neuron projections and their relation to the FasII-positive
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scaffold (Fig. 3A-E). We found that the earlier-born NB5-6T
neurons projected into the lateral-most FasII-positive bundle, as
well as across the anterior commissure, whereas Ap axons can be
observed at St16 joining the medial-most bundle (Fig. 3A-E). With
this information at hand, we introduced the lbe(K)-GFP transgene
into the col and lbe mutants, and assayed the effects upon the
Ap axons, including Tv1. In both col and lbe mutants, we observed
a failure of the Ap axons to project into the medial-most
FasII-positive bundle, apparent both at St16, St17 and stage AFT
(Fig. 3F-H, Fig. S6A-E). In line with the finding that early-born
NB5-6T neurons, which express lbe but not col, project laterally or
across the anterior commissure (Fig. 3A-E), we observed defects in
these projections in lbe mutants, whereas col only affected the
medial-most projections (Fig. 3F,G).
The mutant and misexpression analyses demonstrate that col and
lbe are necessary, and in part sufficient, for Tv1 axon pathfinding.
Similarly, ap and eya are also necessary and, to a lesser extent,
sufficient for Tv1 axon pathfinding. This raises the issue of whether
or not lbe and col act only via ap and eya or whether they have roles
outside this function. To address this, we misexpressed col in the
NB5-6 lineage, using a lbe(K)-Gal4, UAS-EGFPF combination, in
control as well as in ap and eya mutants. Because of the effect of
single misexpression of lbe from wg-Gal4, i.e. routing of axons into
the lateral-most FasII-positive bundle, we overexpressed lbe in ap or
eyamutants. We analysed abdominal segments, because the lack of
Ap neurons in the NB5-6A lineages (Karlsson et al., 2010) results in
the absence of axons from this lineage in the medial-most FasII-
positive bundle (Fig. S7A). In control, similar to the effects of
elav-Gal4 and wg-Gal4, misexpression of col from lbe(K)-Gal4
triggers ectopic axon projections into the medial-most FasII-
positive bundle (Fig. S7B). Strikingly, in both ap and eya
mutants, col is still able to trigger these ectopic axon projections
(Fig. S7C-F).
To summarize, col, lbe, ap and eya are all crucial for proper axon
pathfinding of Ap neurons, including the Tv1 neuron. Although col/
lbe co-misexpression robustly activates Ap and Eya, the weaker
effects of ap/eya co-misexpression and the misexpression effects of
col in ap or eya mutant backgrounds indicate that col and lbe have
axon pathfinding roles in addition to their activation of ap and eya.
Transcriptomeanalysis ofcol/lbeco-misexpression embryos
reveals activation of the Tv1 cell fate cascade
Co-misexpression of col/lbe results in robust reprogramming of
many neurons to Tv1 cell fate, as apparent from ectopic expression
of the Tv1 regulatory cascade (Ap, Eya and Dimm), the Nplp1
neurotransmitter and Tv1-like axon pathfinding. These results
suggested that col/lbe co-misexpression followed by transcriptome
analysis of embryonic RNA could allow for the identification of the
entire Tv1 cell signature, as well as identify novel regulators and
effectors involved in Tv1 fate. To this end, we co-misexpressed
Fig. 2. col and lbe are sufficient for axon projection along the medial FasII-positive bundle. (A-D) Control (A,C) and UAS-col,lbe co-misexpression
(B,D), driven by the row 5 NB driver wg-Gal4,UAS-EGFPF (farnesylated GFP, targeted to cell membranes), stained for GFP, FasII and Nplp1 (in C,D).
(A,C) In control, at St16 and AFT, neurons generated by row 5 NBs project axons along different pathways, including several of the longitudinal FasII-positive
bundles, as well as themotor nerves. (B,D) In col/lbe co-misexpression, axons ectopically project primarily along themedial-most FasII-positive bundle, and there
is an apparent loss of motor nerve projections. (C,D) col/lbe co-misexpression driven bywg-Gal4 also triggers ectopic Nplp1 expression, albeit to a lesser degree
than with elav-Gal4. Genotypes: (A,C) wg-Gal4, UAS-EGFPF/+; (B,D) wg-Gal4, UAS-EGFPF/+; UAS-col,UAS-lbe/+.
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lbe/col and analysed the transcriptome, using whole-embryo
RNA-seq, both at St16 and stage AFT.
As anticipated, we found that the entire known Tv1 regulatory
cascade was activated, including ap, eya and dimm, as well as
Nplp1, both at St16 and stage AFT (Fig. S8A,B). As noted above,
owing to the temporal progression of the Ap neuron regulatory
cascade (Baumgardt et al., 2009, 2007; Gabilondo et al., 2016;
Stratmann et al., 2016), col/lbe co-misexpression does not trigger
ectopic expression of the FMRFa neuropeptide (Fig. S1A-N)
(Gabilondo et al., 2016), which is expressed by the Tv4 Ap neurons.
In linewith these previous findings, we did not observe upregulation
of the FMRFa gene (Fig. S8A,B).
col/lbe co-misexpression activates dimm and, therefore, the
regulated secretory pathway
Previous studies have demonstrated that dimm controls the regulated
secretory pathway, being both necessary and sufficient to directly
activate a number of genes in this pathway (Allan et al., 2005;
Hamanaka et al., 2010; Hewes et al., 2006; Park et al., 2011, 2004,
2014, 2008a,b). Because col/lbe activates dimm expression, we
analysed the expression of 21 of the previously identified dimm
target genes in the regulated secretory pathway. This analysis
revealed that col/lbe co-misexpression significantly activated
expression of 14 of these 21 genes, with the remaining six
showing a trend upwards, albeit non-significant (Fig. S8C).
col/lbe and ap/eya co-misexpression regulates axon
pathfinding genes
Next, we turned to the axon pathfinding aspect of Tv1 cell fate.
Because the aforementioned results showed that not only col/lbe but
also ap/eya are involved in the axon pathfinding of Tv1 neurons
(this study; Lundgren et al., 1995; Miguel-Aliaga et al., 2004),
we also analysed the transcriptome for combinatorial and single
misexpression of all four genes. Focusing first on co-misexpression
of col/lbe versus ap/eya, at stage AFT, this analysis revealed
twofold changes (2FC) in expression of 1075 and 650 genes,
respectively (Fig. 4A,B). A smaller number of genes showed
altered expression at St16 (Fig. S9A,E). There was considerable
overlap in the gene expression profiles, with 458 genes affected by
both col/lbe and ap/eya (Figs S9E, S10B). Gene ontology (GO)
filtering of the overlapping set of genes revealed a diverse set of
molecular functions, biological processes and cellular components
(Fig. S10A-C).
GO filtering for the 416 Drosophila genes identified as ‘neuron
projection development’ revealed that col/lbe and ap/eya
co-misexpression altered expression of 13 and seven of these
genes, respectively (Fig. 4A,B). As anticipated, col itself (knot; kn)
was identified in the col/lbe co-misexpression samples, as well as ap
and eya in the ap/eya co-misexpression samples (Fig. 4A,B).
Surveying the overlap in gene expression between col/lbe and ap/
eya within the GO category ‘neuron projection development’, we
Fig. 3. col and lbe are necessary for axon projection along the medial FasII-positive bundle. (A-E) Axon projections of all NB5-6T neurons at St16-St17,
visualized using lbe(K)-Gal4>UAS-EGFPF, and of Ap neurons, visualized using apC-tau-lacZ, stained for β-gal, GFP and FasII. Ap axons label a subset of NB5-6T
neurons and project into the medial-most FasII-positive bundle (blue arrowheads). (F-H) Axon projections of NB5-6T neurons at St16, visualized using
lbe(K)-Gal4>UAS-EGFPF, in control, col and lbemutants. In control, the Ap cluster neurons in NB5-6T, including the Tv1 neuron, project into the medial-most FasII-
positive bundle. In col and lbemutants, these axonal projections towards themedial FasII-positive bundle are absent (blue arrowheads). Genotypes: (A-C) apC2.1-
tau-lacZ/ lbe(K)-Gal4/UAS-EGFPF; (F) lbe(K)-Gal4, UAS-EGFPF/+; (G) col1/col3; lbe(K)-Gal4/UAS-EGFPF; (H) lbe(K)-Gal4/UAS- EGFPF; lbe12C5/lbeDf.
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identified five genes whose expression was changed twofold in both
genotypes, indicating that those factors are regulated by col/lbe via
ap/eya. In addition to ap and eya themselves, these were: jelly belly,
which was up-regulated; and ftz-f1 and Neurotrophin 1 (NT1),
which were downregulated (Fig. 4C).
The nerfin-1 and Dbx genes control axon pathfinding
Next, we focused on the eight ‘neuron projection development’
genes regulated by col/lbe and not by ap/eya. To address the
combinatorial action of col/lbe, we chose to include the RNA-seq
results from the col and lbe single misexpression in the heatmap,
regardless of their fold-change value. We find a strong
combinatorial effect in the RNA-seq data of col/lbe on nerfin-1
(zinc finger, C2H2-type; vertebrate: NSM1/2), which is upregulated
by lbe/col co-misexpression, but not in the col and lbe single
misexpression experiments (Fig. 4D). This effect was confirmed by
in situ hybridization, which revealed an apparent upregulation
of nerfin-1 in the elav>col,lbe embryonic VNC (Fig. 5I-J). Previous
studies of nerfin-1 have revealed that its mRNA is expressed
by most, if not all, VNC NBs, with Nerfin-1 protein being
restricted to a subset of NBs and their daughter cells (Kuzin et al.,
2005; Stivers et al., 2000). Both nerfin-1mutants andmisexpression
Fig. 4. See next page for legend.
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resulted in axon-pathfinding defects in the developing VNC (Kuzin
et al., 2005). To test the roles of nerfin-1 in Tv1 axon pathfinding,
we analysed mutants and misexpression at stage AFT, and
monitored potential pathfinding by staining for FasII and Nplp1.
nerfin-1 mutants showed strongly disorganized FasII-positive
axon bundles and, in addition, disorganized or absent Nplp1-
positive axons (Fig. 4E,F). Misexpression of nerfin-1 from
elav-Gal4 showed a milder phenotype with respect to the FasII-
positive bundles, but disorganized Nplp1 axon projections, which
fail to project towards the medial-most FasII-positive bundle
(Fig. 4G). Strikingly, however, Nplp1 expression was apparently
unaffected in nerfin-1 mutants or misexpression (Fig. 4J). On
analysing Nerfin-1 expression, we found that Nerfin-1 is expressed
in the NB5-6T lineage and Ap cluster neurons, evident by
overlap with lbe(K)-GFP and Eya, at St14 and late St15
(StL15). At St16, Nerfin-1 expression is absent from the Ap
cluster (Fig. S11A-D). This prompted us to test whether Nerfin-1
can be activated or maintained in the NB5-6T lineage at St16,
when col/lbe are co-misexpressed from the NB5-6 lineage-specific
driver lbe(K)-Gal4. Indeed, we find that col/lbe co-misexpression
results in a minor, yet significant, increase of Nerfin-1-positive
cells in the NB5-6T lineage (Fig. 5A,B,G). Next, we quantified
Nerfin-1-positive cells in col and lbe mutants in the NB5-6T
lineage. Based upon the dynamic Nerfin-1 expression, we decided
to assess Nerfin-1 cell numbers at an earlier stage than St16,
i.e. StL15. However, quantification of Nerfin-1-positive cells in
both col and lbe mutants did not show any significant differences
in cell number (Fig. 5C,D,G). We further analysed the expression of
Nerfin-1 in ap and eya mutants, and, in line with the lack of
upregulation of nerfin-1 by elav>ap,eya in the RNA-seq data,
mutant analysis did not reveal any apparent effects on Nerfin-1
expression (Fig. S12A-H).
In contrast to nerfin-1, the RNA-seq revealed thatDbx (homeobox
factor; vertebrate: DBX1/2, BARX1) was downregulated in
lbe/col co-misexpression, and also strongly affected by a single
misexpression of lbe (Fig. 4D). Similarly, RNA-seq at St16 revealed a
strong combinatorial effect of lbe/col onDbx (Fig. S9D). In line with
these findings, col/lbe co-misexpression, from elav-Gal4, resulted in
significantly decreased numbers of Dbx cells, both in thoracic and
abdominal segments (Fig. 6A,B,G). However, col or lbemutants did
not show significant differences in Dbx-positive cells, in either
thoracic or abdominal segments (Fig. 6C-F,H,I). Previous studies
revealed thatDbxmutants did not show an apparent axon pathfinding
phenotype, whereasDbxmisexpression led to a decrease in the ability
of many neurons to extend axons (Lacin et al., 2009). In agreement
with this, we observed apparently intact FasII-positive bundles inDbx
mutants. In contrast, there were severe effects on the axon projections
of the Nplp1 axons, characterized by a failure to project along the
medial-most FasII-positive bundle (Fig. 4H). Dbx misexpression,
under control of elav-Gal4, showed no apparent effect on the FasII-
positive bundles, but projection defects of Nplp1 axons along the
medial-most FasII-positive bundle (Fig. 4I). Quantification of Nplp1-
positive cells in the Dbx mutant and misexpression embryos
surprisingly revealed a partial loss of Nplp1-positive cells in both
cases (Fig. 4J). These findings prompted us to further address
the effect of Dbx on Tv1 cells, by analysing additional Tv1/Ap
cluster markers, at stage AFT. Looking first at Col, Ap, Eya and
Nplp1, we noted that whereas Ap clusters were present in each hemi-
segment of both Dbx and misexpression mutants, there was an
apparent mis-specification of the Ap cluster cells, with a frequent
loss of Nplp1 expression (Fig. S13A-G). However, we also
noted some cases of an extra Nplp1-expressing cell in the Ap
cluster (Fig. S13A-G). This notion was confirmed by analysis of
Dimm, together with Ap, Eya and Nplp1, which also revealed that
both Dbx and misexpression mutants displayed a mixed phenotype
with either loss of, or extra, Dimm cells in the Ap cluster (Fig. S14A-
E). Previous studies on Dbx revealed it to be expressed in neurons
stemming from five NBs, none of which corresponds to NB5-6 or
NB4-3 (Lacin et al., 2009) (the NBs that generate Ap neurons);
indeed, we observed no apparent overlap between Dbx and Ap in
postmitotic cells (Fig. 6A). To determine whether Dbx is expressed
earlier in the NB5-6T lineage, perhaps in the NB itself, we analysed
Dbx expression in NB5-6T during St12-St14. However, we did
not, detect any apparent expression in the lineage at these stages
(Fig. S15A-F).
Analysis of 1.5FC revealed Tv1 axon pathfinding genes
The scarcity of axon pathfinding genes in the 2FC group in the
RNA-seq data prompted us to analyse genes with a fold-change of
≥1.5. Not surprisingly, this expanded the number of genes with
significantly altered expression to 3174 for elav>col/lbe and 2194
for elav>ap/eya (Fig. S16A,B). This also expanded the subset of
Fig. 4. Transcriptome analysis identifies Dbx and nerfin-1. (A) Venn
diagram of 1075 genes (red circle) with a twofold change (2FC) difference in
TPMs between control (elav-Gal4) and col/lbe co-misexpression (elav-Gal4/
UAS-col,lbe) at stage AFT. GO-term genes involved in neuron projection
and development, containing 416 genes (yellow circle), shows an overlap of
13 genes. Overlapping genes are plotted in a heatmap based on their log2
transformed TPM values. (B) Venn diagram of 650 genes, showing a 2FC
difference in TPMs between UAS-ap,eya co-misexpression at stage AFT
in comparison with the control (elav-Gal4). When this is compared with the
GO-term gene list for neuron projection and development containing 416
genes, there is an overlap of seven genes. Overlapping genes are plotted in a
heatmap based on their log2 transformed TPMvalues. (C) Venn diagramof the
comparison of the 13 genes overlapping between col/lbe co-misexpression
and the GO-gene list (in A) with the seven genes overlapping between ap/eya
co-misexpression and the GO-gene list (in B). Genes overlapping between the
two data sets are shown in the heatmap based on their log2 transformed TPM
values. (D) Venn diagram of the comparison of the 13 genes overlapping
between col/lbe co-misexpression and the GO-gene list (in A) with the seven
genes overlapping between ap/eya and the GO-gene list (in B). The eight
genes altered by col/lbe co-misexpression are shown in the heatmap based on
their log2 transformed TPM values (2FC, vertical black dashed box), including
the TPMs of lbe and col single misexpression. Single misexpression of either
col or lbe has no impact on nerfin-1 expression, whereas the co-misexpression
of col/lbe shows an upregulation compared with both control and single
misexpression experiments (overlap black dashed outlines). Dbx is
downregulated in both col and lbe single misexpression compared with the
control; however, only lbe and col/lbe misexpression downregulate Dbx by
2FC (overlap is indicated by black dashed outlines). (E-I) VNCs stained for
FasII and Nplp1 at stage AFT in control, nerfin-1 and Dbx mutants, and in
misexpression mutants. (F) In nerfin-1 mutants, both the FasII-positive axon
scaffold and projections of the Nplp1-positive cells are severely disrupted.
(G) Misexpression of UAS-nerfin-1 from elav-Gal4 results in distorted axonal
projections of the Nplp1-positive cells, and axons fail to project ipsilaterally and
anteriorly (yellow arrowheads). The FasII-positive axon scaffold, however,
is largely intact. (H) Dbx mutants show no defects with regards to the FasII-
positive axon scaffold. The axon projections of the Nplp1-positive neurons are
severely affected and fail to project along the medial FasII-positive fascicle
(yellow arrowheads). (I) Misexpression of UAS-Dbx from elav-Gal4 shows
axon pathfinding defects with regards to Nplp1-positive axons, while the FasII-
positive fascicles are unaffected (yellow arrowheads). (J) Quantification of
Nplp1-positive cells shows that neither nerfin-1 mutants nor UAS-nerfin-1
misexpression changes the Nplp1-positive cell numbers. Both Dbx mutants
and UAS-Dbx misexpression results in reduced Nplp1-positive cell numbers
(****P≤0.0001, n=3 biological replicates, Student’s t-test; data are mean±s.d.).
Genotypes: (A-D) Control, elav-Gal4/+, misexpression and elav-Gal4/UAS-
cDNAs; (E) OregonR; (F) nerfin-1DF/nerfin-1D159; (G) elav-Gal4/UAS-nerfin-
3xHA; (H) DbxD48/DbxD48; (I) elav-Gal4/UAS-Dbx.
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genes belonging to the ‘neuron projection development’ GO class:
65 for col/lbe and 52 for ap/eya (Fig. S16A,B). Comparing these
two subsets to each other revealed extensive overlap (Fig. S16C).
Given the potent role of col/lbe in controlling Tv1-type axon
projection, in part independent of ap/eya, we focused further upon
the ‘neuron projection development’ genes altered by col/lbe but
Fig. 5. Nerfin-1 expression is activated by col/lbe misexpression, but unaffected in col or lbe mutants. (A,B) VNCs stained for GFP, Ap and Nerfin-1 in
control and UAS-col,lbe co-misexpression in the NB5-6T lineages (cyan dashed lines) under the control of lbe(K)-Gal4 at St16. col/lbe co-misexpression triggers
an increase in Nerfin-1-expressing cells. (C-F) VNCs stained for GFP, Eya and Nerfin-1 in control (C,E), col (D) and lbe (F) mutants at StL15. While Eya
expression is lost in both col and lbe mutants, there is no obvious effect on Nerfin-1 expression. Cyan dashed lines indicate the location of the NB5-6T lineage.
(G) Quantification of Nerfin-1-positive cells in the NB5-6T lineages (outlined in A,B) shows that the col/lbe co-misexpression results in significantly more cells
than in the control (*P=0.01, n≥18 lineages, Student’s t-test; data are mean±s.d.). (H) Quantification of Nerfin-1-positive cells in the NB5-6T lineage (outlined in
C-F) in col and lbemutants reveals no significant differences (n≥18 lineages, Student’s t-test±s.d.). (I,J) RNA fluorescent in situ hybridization for nerfin-1 in control
(I) and elav>col,lbe co-misexpression (J) embryos at St16 in thoracic (T1-T3) and abdominal (A1-A3) VNC segments. (J) In elav>col,lbe co-misexpression,
the nerfin-1 signal is apparently increased, when compared with control (I). Genotypes: (A,C) lbe(K)-Gal4,UAS-EGFPF; (B) lbe(K)-Gal4,UAS-EGFPF/UAS-col,
UAS-lbe; (D) col1/col3;lbe(K)-Gal4/UAS-EGFPF; (E) lbe(K)-GFP; (F) lbe(K)-GFP/+;lbe12C005/lbeDf; (I) OregonR; (J) elav-Gal4/UAS-col,UAS-lbe.
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not ap/eya, and in particular those most effectively regulated by
col/lbe co-misexpression as opposed to single misexpression.
In this group, several of the upregulated genes stood out based
upon their previously described roles in ‘neuron projection
development’, including golden goal (gogo), uncoordinated-104
(unc-104) and futsch (Fig. S16D) (Berger et al., 2008; Hummel
et al., 2000; Medina et al., 2006; Roos et al., 2000; Tomasi et al.,
2008). To address the possible role of these three genes during
Tv1 axon pathfinding, we analysed mutants with the Nplp1 and
FasII markers. None of the mutants displayed loss of Nplp1
expression in cell bodies (Tv1 or dAp). However, gogo and futsch
mutants both displayed an apparent disorganization of Tv1 axons
(Fig. S17A,B,D,E). While unc-104 mutants displayed Nplp1
expression in cell bodies, there was a complete loss of Nplp1-
positive axonal projections (Fig. S17C). The unc-104 phenotype
prompted us to introduce the Nplp1-CRM-myrRFP transgene into
the unc-104 background, which revealed that Tv1 axons did indeed
project normally in this mutant (Fig. S17F,G). This finding is in line
with previous studies, demonstrating that unc-104, which encodes a
Kinesin-like molecule, is crucial for dense core vesicle axon
transport and, hence, neuropeptide transport (Barkus et al., 2008;
Lim et al., 2017).
Fig. 6. col and lbe repress Dbx expression.
(A-F) Embryonic VNCs stained for Ap and Dbx in
control (A,C,E), col/lbe co-misexpression (B), col
mutants (D) and lbe mutants (F) at St16.
(A,B) Misexpression of col/lbe from elav-Gal4
results in ectopic Ap neurons and reduction of
Dbx-expressing cells. (C,D) col mutants show
reduction of Ap cells, but no reduction of Dbx-
positive cells. (E,F) lbe mutants show reduction
of Ap cells, but no reduction of Dbx-positive cells.
(G-I) Quantification of Dbx-positive cell numbers
in thoracic and abdominal segments (example
segments are outlined with dashed white boxes
in A-F). (G) In col/lbe co-misexpression, the Dbx-
positive cell numbers are significantly reduced
compared with control, in both thoracic and
abdominal segments (****P≤0.0001, n≥9
segments, Student’s t-test; data are mean±s.d.).
(H) In col mutants the Dbx-positive cell numbers
are not affected (n=9 segments, Student’s t-test;
data are mean±s.d.). (I) In lbe mutants, the Dbx-
positive cell numbers are not affected (n=9
segments, Student’s t-test; data are mean±s.d.).
In all cases, Dbx-positive cell numbers are lower
in the abdominal segments than in the thoracic
segments. Genotypes: (A) elav-Gal4/+; (B) elav-
Gal4/UAS-col,UAS-lbe; (C,E) OregonR; (D) col1/
col3; (F) lbeDf/lbe12C00.
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Overlap between transcriptome changes and DNA binding
Previous ChIP-seq analysis of Col, from whole mid-embryo
chromatin, identified ∼400 genes (de Taffin et al., 2015). We
compared this gene list with our RNA-seq lists for elav>col, both
the 1.5-fold change and 2.0-fold change, at St16 and AFT, and
found a number of overlapping genes (Fig. S18A-D). These
included nerfin-1, Dbx and ap. In addition, the Col ChIP-seq study
also identified eya as a direct target of Col (de Taffin et al., 2015).
Previous gene-focused studies have also provided support for direct
binding of Lbe on col, Col on ap, eya and dimm, Ap on dimm and
Nplp1, and Dimm on Nplp1 (Stratmann and Thor, 2017). In
addition, genome-wide analysis of Dimm DNA binding (Hadžic ́
et al., 2015) revealed direct interaction with many of the regulated
secretory pathway genes (genes in red in Fig. S8), and, furthermore,
the direct regulation of Phm has been observed in directed studies
(Park et al., 2008a). Hence, a substantial part of the regulatory
cascade for Tv1 cell fate apparently involves direct gene regulation.
Minimal overlap between CNS RNA-seq data and previous
muscle RNA-array data for Ladybird early
Aprevious studyaddressingLbe target genes inmuscle cells, byusing
muscle-specific RNAi and muscle-specific misexpression, resulting
in the identification of 117 genes with a high fold change (Junion
et al., 2007).We compared these results with our CNS-targeted RNA-
seq data for elav>lbe, both the 1.5-fold change and 2.0-fold change, at
St16 andAFT. In all cases,we notedminimal overlap between theLbe
CNS and muscle target genes (Fig. S19A-D). Not surprisingly, this
indicates that the context (CNS versus muscles) greatly influences
target gene selection by Lbe.
DISCUSSION
Branching terminal selector gene cascade controlling Tv1
neuron identity
The identity of the Tv1 neuron is specified by a genetic cascade that
initially commences with a core pathway FFL: lbe→col→ap/eya
(Baumgardt et al., 2007; Gabilondo et al., 2016). It then forks into
three separate branches, with the first branch being a continued FFL
of col→ap/eya→dimm, which activates Nplp1 neuropeptide
expression (Baumgardt et al., 2007; Gabilondo et al., 2016). Recent
studies indicate that the entire lbe→col→ap/eya→dimm→Nplp1 FFL
is executed via sequential DNA binding by the TFs onto each
enhancer in the cascade (Stratmann and Thor, 2017).
A second branch consists of dimm alone, which is necessary and
sufficient to activate the regulated secretory pathway, including the
neuropeptide-processing machinery and the large dense-core
vesicle machinery (Allan et al., 2005; Hamanaka et al., 2010;
Hewes et al., 2006; Park et al., 2011). Dimm directly activates Phm,
and possibly syta and sytb (Park et al., 2014, 2008a), and acts
directly on many other genes in the regulated secretory pathway
(Hadžic ́ et al., 2015). Evidence points to Dimm also acting directly
on Nplp1 (Stratmann and Thor, 2017), as well as on other
neuropeptide genes (Gauthier and Hewes, 2006), and it appears to
play a dual role in both activating the regulated secretory pathway
and acting combinatorially to activate neuropeptide gene expression
(Baumgardt et al., 2007). We find that col/lbe co-misexpression,
which ectopically activates dimm in the CNS, results in the
activation of most of the previously identified Dimm targets in the
regulated secretory pathway.
In contrast to the central role of dimmwith respect to the regulated
secretory pathway, dimm does not affect axon pathfinding of Tv1
neurons (Allan et al., 2005). Instead, axon pathfinding is controlled
by the third branch, where the col→ap/eya and lbe→col→nerfin-1
FFLs are important for Tv1 axon pathfinding, ensuring that Tv1
axons project towards the midline and join the medial-most FasII-
positive fascicle. In line with this model, nerfin-1 does not affect
Nplp1 expression, only pathfinding. The transcriptome and genetic
analysis further suggests that the axon pathfinding FFL is itself
divided into sub-branches, where col/lbe activate the effectors
unc-104, gogo and futsch, while ap/eya activate (for example) jeb
and dnc. Because col/lbe activate ap/eya, we cannot rule out a model
whereby genes activated by col/lbe but not by ap/eya still require the
combinatorial action of col/lbe/ap/eya. However, the lack of ectopic
and mutant effects on (for example) nerfin-1 argues against such a
model, at least regarding this downstream target. Thus, the
specification of the Tv1 neuron commences with a core initial
terminal selector FFL pathway, which branches out into different
FLLs, each of which executes different sub-routines that are crucial
for final Tv1 identity (Fig. 7). The results from both genome-wide
and directed DNA-binding studies (de Taffin et al., 2015; Hadžic ́
et al., 2015; Park et al., 2008a; Stratmann and Thor, 2017) support
the hypothesis that these FFLs play out via sequential direct DNA-
binding of TFs onto the downstream genes (genes in red in Fig. 7 are
predicted to be direct targets for one or several of the upstream TFs).
Fig. 7. Genetic pathways specifying Tv1 neuron cell fate. The Tv1 cell fate
specification cascade. lbe, which is selectively expressed by NB5-6 andNB5-3
(De Graeve et al., 2004), acts with the Hox gene Antp and the Hox co-factors
hth and exd, as well as the temporal factor cas, to trigger expression of col. This
triggers a feed-forward loop (FFL), modulated by Dbx, including the genes ap,
eya and dimm, which act in a combinatorial manner with lbe and col to specify
the terminal cell fate of the Tv1 neuropeptide cells. However, this FFL forks into
three different branches, each of which control different subroutines essential
for complete Tv1 cell fate. One branch consists of col→ap/eya→dimm, which
activates Nplp1 neuropeptide expression (Baumgardt et al., 2007; Gabilondo
et al., 2016; Stratmann and Thor, 2017). A second branch consists of dimm
alone, which is necessary and sufficient to activate the regulated secretory
pathway, including the neuropeptide-processing machinery and the large
dense-core vesicle machinery (Allan et al., 2005; Hadzic et al., 2015;
Hamanaka et al., 2010; Hewes et al., 2006; Park et al., 2011, 2014, 2008a,b).
The third branch consists of the col→ap/eya and lbe→col→nerfin-1 FFL, which
are important for Tv1 axon pathfinding, ensuring that Tv1 axons project
towards the midline and join the medial-most FasII-positive fascicle. In line
with this model, nerfin-1 does not affect Nplp1 expression, only pathfinding.
Potential downstream factors important for axonal pathfinding are shown in
grey, and include jeb, futsch, dnc, Mmp1 and ash2. Thus, the specification of
the Tv1 neuron commences with a core initial terminal selector FFL pathway,
which branches out into different FLLs, each of which executes different
sub-routines crucial for the final Tv1 identity (Fig. 7). Genes in red are putative
direct targets of the upstream TFs (see text for details).
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The pleiotropic effects of Dbx on Tv1 neuron specification, with
both mutants and misexpression affecting several Tv1 properties,
including Nplp1 expression, Ap cluster composition and axon
pathfinding, makes it difficult at this stage to precisely place Dbx
within the Tv1 cascade. However, this pleiotropic action is
reminiscent of other genes acting in the NB5-6T, such as
Kruppel, squeeze, nab and seven up, all of which are dynamically
expressed during the generation of Ap cluster neurons (Allan et al.,
2005; Allan et al., 2003; Baumgardt et al., 2009; Benito-Sipos
et al., 2011; Stratmann et al., 2016; Terriente Felix et al., 2007).
The surprising apparent lack of Dbx expression in Tv1 neurons
or in the NB5-6T lineage may be due to the fact that Dbx is
expressed even earlier than was assayed here, or that certain Dbx
protein variants are not detected with the antibody used.
Alternatively, given the lack of apparent Dbx expression in the
NB5-6T lineage, and as the misexpression of Dbx was conducted
using elav-Gal4, a pan-neural driver, it is possible that both the
mutant and misexpression phenotypes of Dbx reflect non cell-
autonomous effects.
One, perhaps unexpected, finding was that although the
transcriptome analysis of col/lbe co-misexpression did reveal
twofold upregulation of ap, eya, dimm and nerfin-1, it did not
reveal upregulation of any additional TFs. The absence of such TFs
may suggest that the identified regulators for axon pathfinding
(lbe→co→ap/eya/nerfin-1), for Nplp1 (col→ap/eya→dimm) and
for regulated secretory pathway (dimm) may indeed constitute the
main regulators of these subroutines in Tv1 neurons. This notion is
also supported by a recent forward genetic screen, scoring for
expression of FMRFa-eGFP in the Tv4 Ap cluster neurons,
which, although it re-identified lbe, col and eya, did not identify
any other late-acting TFs (Bivik et al., 2015). Another unexpected
result was that we did not observe twofold upregulation of any
obvious axon pathfinding genes, but did identify such genes in
the lower (1.5-fold change) group. This could stem from their
generally broader expression, which may reduce the fold-change
effects in our whole embryo RNA analyses. However, it
should also be noted that filtering solely on the GO term ‘neuron
projection development’ may fail to identify some bona fide axon
pathfinding genes, and also include genes that are not directly
involved in axon pathfinding. Hence, future analysis of the 1075
genes with twofold change and the 3174 genes with 1.5-fold
change, affected by col/lbe co-misexpression, may help identify
additional axon pathfinding genes, as well as further refine the Tv1
neuron genetic cascade.
One terminal selector versus branching FFLs
The specification of the terminal and unique identity of any given
neuron could conceivably be controlled by a number of different
mechanisms (Allan and Thor, 2015; Hobert, 2008, 2016; Hobert
et al., 2010). Theoretically, one can envision two extreme models:
(1) that all aspects of the identity of a neuron could be determined by
a single TF; or (2) that all aspects of the fate of a neuron are
combinatorially regulated, and that, in addition, there could be
considerable branching in the regulatory networks.
Evidence for the first model stems in particular from C. elegans,
where the TF CHE-1 determines most, if not all, aspects
of the identity of a specific gustatory neuron (Etchberger et al.,
2007). These studies, and related findings, led the authors to
coin the term terminal selectors (Wenick and Hobert, 2004).
Similarly, in mammals, the TF Pet-1 acts as a terminal selector,
being a key regulator of serotonin neuron specification, controlling
genes needed for serotonin synthesis, reuptake and vesicular
transport, as well as several other unique features of serotonin
neurons (reviewed by Spencer and Deneris, 2017). This scenario,
of one factor dictating the entire fate of a neuron, may perhaps
have been favoured during evolution, as it may help reduce
regulatory complexity.
Support for the second model emerges from the common
anatomical scenario where neurons expressing the same
neurotransmitter may project axons to different targets. There are
many examples of such divergence between transmitter and
morphology, e.g. different groups of dopaminergic and serotonergic
neurons in the mammalian CNS (Björklund and Dunnett, 2007;
Gaspar and Lillesaar, 2012), as well as neuropeptide-producing
neurons in many systems (Hokfelt et al., 2000; Park et al., 2008b).
Hence, there is an apparent dissociation between neurotransmitter
identity and axonal projections, a biological reality that is not
easily accommodated by one single TF dictating the entire cell fate.
Indeed, studies in C. elegans have revealed that the LIM-homeobox
gene ceh-14 only regulates the neuropeptide expression in BDU
neurons, but not other aspects of this cell fate (Gordon and Hobert,
2015). Based upon the results reported here, and on previous studies,
we find that Tv1 fate is not controlled by one single terminal selector
TF, but rather by several combinatorial TFs codes and one single TF
(dimm), each of which launch different subroutines that are crucial for
Tv1 cell fate.
Having the regulatory code for neurotransmitter identity diverge
from that controlling axonal pathfinding may better accommodate,
even drive, the diverging identities of many neuronal sub-classes
during evolution. Furthermore, it would allow for association and
disassociation between different terminal neuronal cell fate features.
These include association/dissociation of neurotransmitter and
cellular morphology, simultaneous or separate production of
neuropeptides and small neurotransmitters, coupling-uncoupling
of neuropeptide expression with the regulated secretory pathway
(scaling). It is tempting to speculate that evolution may have
progressed from the basic scenario of one-selector-one-fate to a
branching landscape, where every sub-routine of a neuron’s
property is combinatorially controlled, and where several codes
act simultaneously to govern different sub-routines.
MATERIALS AND METHODS
Fly stocks
Location marker and driver lines
Driver lines used were wg758 (referred to as wgGal4; provided by Konrad
Basler, University of Zurich, Switzerland), lbe(K)-Gal4,UAS-EGFPF
[double, i.e. on both chromosome (chr) II and chr III], lbe(K)-EGFP
(Ulvklo et al., 2012), apC2.1-tau-lacZ (chr III) (Lundgren et al., 1995) and
elavC155=elav-Gal4 (Bloomington Drosophila Stock Center 458).
Mutant lines
Mutant lines used were: lbe12C005 (BL#59385); Df(lbl-lbe)B44 (referred to
as lbeDf; provided by Krzysztof Jagla, Clermont University, Clermont-
Ferrand, France); col1 and col3 (Crozatier and Vincent, 1999) (provided by
Alain Vincent, University Paul Sabatier, Toulouse, France); Df(2L)BSC354
(referred to as eyaDf ) (BL#24378); eyacli-IID (BL#3280); apP44 (Bourgouin
et al., 1992); nerfin-1Df (BL#7565); nerfin-1D159 (provided by Alexander
Kuzin and Ward Odenwald, NINDS, Bethesda, MD, USA); DbxD48
(BL#56824); gogoH1657 and gogoD1600 (provided by Takashi Suzuki,
Tokyo Institute of Technology, Yokohama, Japan); futschN94 (BL#8805);
unc-104P350 (BL#24630) and unc-104R757 (BL#24631).
Misexpression lines
Misexpression lines used were: UAS-col-HA and UAS-myc-lbe (Stratmann
et al., 2016); UAS-Flag-ap and UAS-eya-HPC4 (this study); UAS-nerfin-
3xHA (FlyORF #F000461); and UAS-Dbx-3xHA (FlyORF # F001875).
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CRM line
Nplp1-CRM-myrRFP-HA (this study) flies were maintained over GFP- or
YFP-marked balancer chromosomes. Control OregonR was used as wild
type. Staging of embryos was performed according to Campos-Ortega and
Hartenstein (Campos-Ortega and Hartenstein, 1985).
Immunohistochemistry
Primary antibodies used were: chicken anti-proNplp1 (1:1000), rabbit anti-
proFMRFa (1:1000) and guinea pig anti-Dimm (1:1000) (Baumgardt et al.,
2007); mouse mAb anti-Eya 10H6 (1:250) and mAb anti-FasII ID4 (1:30)
(Developmental Studies Hybridoma Bank); rabbit anti-Ap (1:1000) (Bieli
et al., 2015) (provided by Dimi Bieli and Markus Affolter); guinea pig anti-
Dbx (1:500) (provided by James B. Skeath, Washington University, St
Louis, MO, USA); guinea pig anti-Nerfin-1 (1:500) (provided by Ward
Odenwald, NINDS, Bethesda, MD, USA); and goat anti-GFP (1:1000)
(ab6673, Abcam).
In situ hybridization
A nerfin-1 full-length cDNA (LD18634) was obtained from the Drosophila
Genomics Resource Center. The authenticity of the cDNA was confirmed
by sequencing. The cDNA was linearized using XbaI, and a ribo-probe
generated by T7 polymerase. In situ hybridization was conducted as
previously described (Baumgardt et al., 2007).
Transgenic flies
UAS-constructs
UAS-Flag-ap and UAS-eya-HPC4 were generated by the codon
optimization for expression in Drosophila (www.kazusa.or.jp/codon/).
EcoRI site and consensus start codon (Cavener and Ray, 1991) was added to
the 5′ end. Three different stop codons (amb, och, opa) followed by an XbaI
site were added to the 3′ end (see Table S1 for DNA sequences). DNAs were
generated by gene synthesis (Genscript) and cloned into pUASattB (Bischof
et al., 2007) as EcoRI/XbaI fragments. DNAs were injected into landing site
strains BL#9723 (28E) for UAS-Flag-ap and BL#9744 (89E) for UAS-eya-
HPC4 (BestGene).
Nplp1-CRM-myrRFP-HA construction
To generate the Nplp1-CRM-myrRFP-HA.attB landing site construct, first
the pEGFP.attB landing site vector (Bischof et al., 2013) (provided by
Konrad Basler and Johannes Bischof, University of Zurich, Switzerland)
was cut with NdeI and XmaJI in order to remove the GFP cassette. Cutting
with NdeI creates a TA overhang compatible with a VspI restriction site,
which also creates TA overhangs. A VspI-myrRFP-HA-XmaJI sequence
containing the L21 sequence upstream the ATG start codon (Pfeiffer et al.,
2012) was synthesized at Genescript and delivered in a pUC57 vector
(sequences listed in Table S2). The VspI-myr::RFP-HA-XmaJI construct
was cut from the pUC57 vector with VspI and XmaJI, and ligated into the
empty attB landing site vector to create a myrRFP-HA.attB vector. The
Nplp1 enhancer (Stratmann and Thor, 2017) was generated via PCR on
OregonR DNA (primers listed in Table S2) and cloned into the TOPO
pCR2.1-TOPO TA vector according to the manufacturer’s protocol
(Invitrogen). In order to clone the Nplp1-CRM into the myrRFP.attB
landing site vector, the myrRFP.attB vector was digested with BglII and
XbaI, and the Nplp1-CRM was cut from the TOPO vector with BamHI and
XbaI and subsequently ligated upstream the myrRFP-HA cassette. The
Nplp1-CRM-myrRFP-HA.attB landing site construct integrated into the fly
genome via site directed phiC31 mediated integration (Bischof et al., 2007)
at BestGene. Stocks for injection were BL#8622 and BL#9723.
RNA-sequencing
Pereach sample∼200 embryosofSt16 and stageAFTwere collected andRNA
was isolated from whole embryos (Qiagen RNeasy Mini kit, 74104). For each
genotype and stage, three independent biological replicates were prepared.
RNA-sequencing library preparation was carried out using the NEBNext Ultra
RNA Library Prep Kit for Illumina by following manufacturer’s
recommendations (NEB). The samples were sequenced on the Illumina
Hiseq 2500 platform using a 1×50 bp configuration for all stage AFT samples
and a 2×150 bp paired end configuration for all St16 samples, with a depth of
∼30-50 million reads. (GeneWiz). FASTQ files were pseudoaligned to the
Drosophila melanogaster coding sequences (CDS, BDGP6, ensemble.org),
abundances of transcripts were determined using Kallisto (release 0.43.1) as
transcripts per million (TPM) units (Bray et al., 2016). Genes of interest
were identified based onTPMsbeingdifferent byat least 2FCs andoverlapping
with the GO-term gene list GO0031175 neuron-projection-development
for Dmel (amigo.geneontology.org/amigo/term/GO:0031175). Genes are
presented in heatmaps and Venn diagrams. The RNA-seq files have been
deposited in GEO under accession number GSE113260.
Confocal imaging and data acquisition
Zeiss LSM700 or LSM800 confocal microscopes were used for fluorescent
images; confocal stacks were merged using LSM software or ImageJ FIJI.
Statistic calculations were performed in Graphpad prism software (v4.03).
Cell counts and reporter (GFP) measurements were carried out using ImageJ
FIJI and numbers were transferred to Graphpad prism. To address statistical
significance, Student’s t-test was used. Images and graphs were compiled in
Adobe Illustrator. The numerical data underlying the graphs in the figures
are included in Table S3.
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Garcıá, P., Bahrampour, S., Thor, S. and Benito-Sipos, J. (2016). Neuronal cell
fate specification by the convergence of different spatiotemporal cues on a
common terminal selector cascade. PLoS Biol. 14, e1002450.
Gaspar, P. and Lillesaar, C. (2012). Probing the diversity of serotonin neurons.
Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 2382-2394.
Gauthier, S. A. and Hewes, R. S. (2006). Transcriptional regulation of neuropeptide
and peptide hormone expression by the Drosophila dimmed and cryptocephal
genes. J. Exp. Biol. 209, 1803-1815.
Gordon, P. M. and Hobert, O. (2015). A competition mechanism for a homeotic
neuron identity transformation in C. elegans. Dev. Cell 34, 206-219.
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